UMM Institutional Repository

STUDI PENGGUNAAN ORAL ANTIDIABETIC DRUG (OAD) PADA PASIEN DIABETES MELITUS TIPE 2 (Penelitian di Rumah Sakit Umum Daerah Kabupaten Kediri)

Fadilah, Fatwa Nur (2018) STUDI PENGGUNAAN ORAL ANTIDIABETIC DRUG (OAD) PADA PASIEN DIABETES MELITUS TIPE 2 (Penelitian di Rumah Sakit Umum Daerah Kabupaten Kediri). Bachelors Degree (S1) thesis, University of Muhammadiyah Malang.

[img]
Preview
Text
PENDAHULUAN.pdf

Download (666kB) | Preview
[img]
Preview
Text
BAB I.pdf

Download (952kB) | Preview
[img]
Preview
Text
BAB II.pdf

Download (12MB) | Preview
[img]
Preview
Text
BAB III.pdf

Download (818kB) | Preview
[img]
Preview
Text
BAB IV.pdf

Download (942kB) | Preview
[img] Text
BAB V.pdf
Restricted to Registered users only

Download (3MB)
[img] Text
BAB VI.pdf
Restricted to Registered users only

Download (6MB)
[img] Text
BAB VII.pdf
Restricted to Registered users only

Download (415kB)
[img] Text
LAMPIRAN.pdf
Restricted to Registered users only

Download (632kB)

Abstract

Background : DM is a chronic metabolic disorder characterized by hyperglicemia associated with carbohydrate, protein, and fatty metabolism disorders caused by defects of insulin, insulin sensitivity or both. There are seven types of OAD with the different mechanism in lowering and controlling blood glucose levels such as biguanide, sulfonylurea, meglitinide, tiazolidinedione, α glucosidase inhibitor, SGLT2 inhibitor, DPPIV inhibitor. Objective : The study aim to know the pattern of OAD therapy in type two diabetes mellitus patients at Regional Public Hospital of Kediri. Method : This study is an observasional study in form of a retrospective descriptive study of type two diabetes mellitus patients at Regional Public Hospital of Kediri. Result and Conclusion The paterns of single OAD therapy given in 11 patients (23%), two combinations in 21 patients (44%), three combinations in 13 patients (27%), four combinations in 3 patients (6%). The patern of two combinations with the most of used is Metformin (3x500 mg) PO + Novorapid® (3x10 IU) SC in 3 patients (12%). The patern of three combinations with the most of used are Metformin (2x500 mg) PO + Novorapid® (3x10 IU) SC + Levemir® (1x10 IU) SC, Metformin (2x500 mg) PO + Novorapid® (3x10 IU) SC + Levemir® (1x14 IU) SC, Metformin (2x500 mg) PO + Novorapid® (3x12 IU) SC + Levemir® (1x14 IU) SC each as many as 1 patient (8%).

Item Type: Thesis (Bachelors Degree (S1))
Student ID: 201410410311069
Keywords: OAD, type 2 diabetes mellitus, hospitalization
Subjects: R Medicine > RZ Other systems of medicine
Divisions: Faculty of Health Science > Department of Pharmacy (48201)
Depositing User: Nurhadin Nurhadin
Date Deposited: 21 Nov 2018 02:34
Last Modified: 21 Nov 2018 02:34
URI : http://eprints.umm.ac.id/id/eprint/40451

Actions (login required)

View Item View Item
UMM Official

© 2008 UMM Library. All Rights Reserved.
Jl. Raya Tlogomas No 246 Malang East Java Indonesia - Phone +62341464318 ext. 150, 151 - Fax +62341464101
E-Mail : infopus[at]umm.ac.id - Website : http://lib.umm.ac.id - Online Catalog : http://laser.umm.ac.id - Repository : http://eprints.umm.ac.id

Web Analytics

UMM Institutional Repository is powered by :
EPrints Logo